Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093262 | 0.78 | MAPT (0.59) | KDM4EMEN1KMT2ARAB9AALDH1A1 | |
| SCHEMBL11661462 | 0.77 | MAPT (0.57) | KDM4EMEN1KMT2ARAB9AALDH1A1 | |
| SCHEMBL5564296 | 0.76 | CA12 (0.54) | HPGDMEN1KMT2AALDH1A1 | |
| SCHEMBL23440267 | 0.75 | KDM4E (0.51) | SCN9AKDM4EMEN1KMT2ACA2 | |
| SCHEMBL3477694 | 0.75 | BRD4 (0.52) | SCN9AKDM4EHPGDMEN1KMT2A | |
| SCHEMBL2999261 | 0.74 | KMT2A (0.64) | KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL28575293 | 0.74 | ALDH1A1 (0.61) | KDM4EMEN1KMT2ACA2ALDH1A1 | |
| SCHEMBL29441805 | 0.74 | — | — | |
| SCHEMBL7243110 | 0.73 | MAPK1 (0.61) | SCN9AMEN1KMT2ABRD4 | |
| SCHEMBL3154182 | 0.72 | SCN3A (0.61) | MEN1KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112812998-A | New strain for degrading sulfamethoxazole and application thereof | 宋金龙 | 2021-05-18 | — | — | CN | disclosed |